Should Global Health be Tailored Toward the Rich? Altruism and Efficient R&D for Neglected Diseases
fhep · 2013
DOI: 10.1515/fhep-2012-0036 ↗Kurz gefasst
Fachartikel in der Zeitschrift fhep, 2013. Verfasst von Anupam B Jena und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Care Policy, Harvard Medical School; and Massachusetts General Hospital; and National Bureau of Economic Research.
Abstract (Originalsprache)
We analyze the problem of incentivizing research and development (R&D) into developing world disease from an economic efficiency perspective. We view the problem as how to best promote R&D into goods with positive external effects in the sense that medicines that directly affect the health of the poor also indirectly affect the utility of the altruistic “rich.” We demonstrate why existing policy proposals – such as price concessions by manufacturers – adversely impact the poor by placing the burden of R&D only on innovators rather than all altruists in the rich world. We offer policy solutions that are based on economic efficiency and therefore rely on a broad sense of how the world values the treatment of developing world disease. We estimate that global altruism toward those with malaria is, at a minimum, valued between $835 million and $2.4 billion annually and for HIV/AIDS, between $9.1 billion and $26.6 billion annually. We argue that future policies toward neglected diseases need to better incorporate how efficient R&D meets the need of this global altruism.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Care Policy, Harvard Medical School; and Massachusetts General Hospital; and National Bureau of Economic Research.
- School of Public Administration, Dalhousie University.
- Irving B. Harris Graduate School of Public Policy Studies, University of Chicago; and National Bureau of Economic Research.
Zitieren
APA
Jena, A. B., Mechoulan, S., & Philipson, T. J. (2013). Should Global Health be Tailored Toward the Rich? Altruism and Efficient R&D for Neglected Diseases. fhep. https://doi.org/10.1515/fhep-2012-0036
Vancouver
Jena AB, Mechoulan S, Philipson TJ. Should Global Health be Tailored Toward the Rich? Altruism and Efficient R&D for Neglected Diseases. fhep. 2013. doi:10.1515/fhep-2012-0036
BibTeX
@article{Jena2013,
author = {Jena, Anupam B and Mechoulan, Stéphane and Philipson, Tomas J},
title = {Should Global Health be Tailored Toward the Rich? Altruism and Efficient R&D for Neglected Diseases},
journal = {fhep},
year = {2013},
doi = {10.1515/fhep-2012-0036}
}
EUVIMED